Role of Uric Acid in Cardiovascular and Renal Disease
Role of Uric Acid in Cardiovascular and Renal Disease
批准号:
7475588
负责人:
Richard Joseph Johnson
金额:
$38.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-01 至 2008-10-17
关键词:
AccountingAdipocytesAnimal ModelBiological AvailabilityBloodBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemCellsClinical TrialsConditionCoupledCultured CellsDevelopmentDiabetes MellitusEnergy IntakeEpidemicFructoseFundingGoalsHypertensionHyperuricemiaInflammationInsulin ResistanceIntakeKidney DiseasesLeadLightLinkLipidsMetabolic syndromeModelingNitric OxideObesityOverweightPathogenesisPathway interactionsPatternPhenotypePlayPopulationProcessPublishingRangeRattusRenin-Angiotensin SystemRisk FactorsRoleSecondary toSerumSmooth Muscle MyocytesSweetening AgentsSyndromeSystemTestingUncertaintyUric AcidVascular Diseasesauthoritybasehuman studyinsightnovel strategiespreventsugar
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Role of Uric Acid in Cardiovascular and Renal Disease We are currently having an epidemic of obesity, with two-thirds of the US population either overweight or frankly obese. Twenty-seven percent of our population have the metabolic syndrome, a known prediabetic condition, and 7% have diabetes. It is critical that we identify potential mechanisms to account for this great epidemic. While there are no doubt multiple causes, including excessive caloric intake and physical inactivity, we have identified another possible mechanism. Specifically, fructose, present in certain sweeteners and sugar, can rapidly induce metabolic syndrome in rats and has also been epidemiologically linked with the rise in obesity. Fructose is unlike all other sugars in that it raises uric acid rapidly in the blood. During the previous RO-1 we have found that uric acid has multiple effects on blood pressure, vascular disease, kidney disease and inflammation, and in particular we have found that uric acid can reduce nitric oxide release from vascular cells. We have further shown that fructose, by way of increasing uric acid, can cause obesity, insulin resistance and lipid abnormalities in rats, and that this can be partially prevented by lowering uric acid. In this application we will further investigate the mechanism by which uric acid contributes to this syndrome, and also dissect how fructose activates this pathway that leads to obesity and the metabolic syndrome. Studies will include determining the critical features about fructose that are necessary to induce the syndrome, with an emphasis on the type of fructose and its role in hypertension. We will also investigate how the rise in uric acid secondary to fructose causes features of the syndrome, with an emphasis on how fructose and uric acid disturb the normal vasculature, converting it from a noninflamed and dilated system to one that is inflamed and constricted. Finally, we will explore the possibility that fructose and uric acid may have direct effects on fat cells. Understanding the pathways by which uric acid, and fructose, can cause metabolic syndrome may give new insights into the pathogenesis of the obesity epidemic, with its impact on cardiovascular and kidney disease.
Project Narrative: This study looks at the role of uric acid and fructose in the development of metabolic syndrome. The role of these factors in this syndrome, have not been widely studied. Identifying a casual role for these factors could lead to new treatments for metabolic syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
-
批准号:10221502
-
项目类别:
-
资助金额:$123.33万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
-
批准号:10441315
-
项目类别:
-
资助金额:$116.39万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease
-
批准号:10265352
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
-
批准号:10659119
-
项目类别:
-
资助金额:$115.2万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
A Novel Mechanism for Sarcopenia in Chronic Kidney Disease
-
批准号:10454871
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
-
批准号:10022080
-
项目类别:
-
资助金额:$125.99万
-
财政年份:2019
-
负责人:Richard Joseph Johnson
-
依托单位:
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome
-
批准号:9114329
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2016
-
负责人:Richard Joseph Johnson
-
依托单位:
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity
-
批准号:9464351
-
项目类别:
-
资助金额:$28.94万
-
财政年份:2015
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease
-
批准号:9275427
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease
-
批准号:8966551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease
-
批准号:9789159
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Richard Joseph Johnson
-
依托单位:
Fructokinase and Nondiabetic and Aging-Associated Chronic Kidney Disease
-
批准号:8735238
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Richard Joseph Johnson
-
依托单位:
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI
-
批准号:8606240
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2013
-
负责人:Richard Joseph Johnson
-
依托单位:
PROINFLAMMATORY ROLE OF URIC ACID IN LUNG DISEASE: NOVEL MODELS AND CLINICAL VALI
-
批准号:8444228
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2013
-
负责人:Richard Joseph Johnson
-
依托单位:
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating
-
批准号:8046591
-
项目类别:
-
资助金额:$227.14万
-
财政年份:2010
-
负责人:Richard Joseph Johnson
-
依托单位:
Endothelial Cell in Progressive Renal Disease
-
批准号:7919178
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2009
-
负责人:Richard Joseph Johnson
-
依托单位:
Uric Acid and Hypertension in African-Americans
-
批准号:7271341
-
项目类别:
-
资助金额:$68.73万
-
财政年份:2005
-
负责人:Richard Joseph Johnson
-
依托单位:
Uric Acid and Hypertension in African-Americans
-
批准号:6964100
-
项目类别:
-
资助金额:$70.88万
-
财政年份:2005
-
负责人:Richard Joseph Johnson
-
依托单位:
Uric Acid and Hypertension in African-Americans
-
批准号:7105071
-
项目类别:
-
资助金额:$70.42万
-
财政年份:2005
-
负责人:Richard Joseph Johnson
-
依托单位:
Role of Uric Acid in Cardiovascular and Renal Disease
-
批准号:7802857
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2002
-
负责人:Richard Joseph Johnson
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: